Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAA50 | Q9GZZ1 | 2/20 | 0.85 |
| ▸ | CHAT | P28329 | 2/20 | 0.82 |
| ▸ | EP300 | Q09472 | 3/20 | 0.80 |
| ▸ | KAT5 | Q92993 | 2/20 | 0.80 |
| ▸ | AURKA | O14965 | 2/20 | 0.80 |
| ▸ | KAT2B | Q92831 | 1/20 | 0.80 |
| ▸ | CREBBP | Q92793 | 1/20 | 0.72 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL366095 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Dodecanoyl-Coa SCHEMBL4309283 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL2934083 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL1756475 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Decanoyl-Coa SCHEMBL24667667 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL1129961 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Octanoyl-Coa SCHEMBL24667663 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL11027446 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| Octanoyl-Coa SCHEMBL2370508 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA | |
| SCHEMBL20970006 | 1.00 | NAA50 (0.85) | NAA50CHATEP300KAT5AURKA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 62 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022241299-A2 | ENGINEERED ENZYMES, CELLS, AND METHODS FOR PRODUCING CANNABINOID PRECURSORS AND CANNABINOIDS | CELLIBRE, INC. (US) | 2022-11-17 | — | — | WO | claimed |
| CN-114207108-A | Genetically modified host cells producing glycosylated cannabinoids | 奥克塔林生物制剂公司 | 2022-03-18 | — | — | CN | claimed |
| EP-4638753-A2 | PRODUCTION OF CANNABINOIDS AND ENGINEERED CELLS THEREFOR | Cellibre, Inc. (US) | 2025-10-29 | — | — | EP | disclosed |
| CN-111699194-B | Lipid production | 赢创运营有限公司 | 2024-12-13 | — | — | CN | disclosed |
| US-20240360425-A1 | ENGINEERED ENZYMES, CELLS, AND METHODS FOR PRODUCING CANNABINOID PRECURSORS AND CANNABINOIDS | CELLIBRE, INC. | 2024-10-31 | — | — | US | disclosed |
| US-20240327874-A1 | Yeast cells and methods for production of E8,E10-dodecadienyl coenzyme A, codlemone and derivatives thereof | FMC Agricultural Solutions A/S (DK) | 2024-10-03 | — | — | US | disclosed |
| WO-2024138205-A2 | PRODUCTION OF CANNABINOIDS AND ENGINEERED CELLS THEREFOR | CELLIBRE, INC. (US) | 2024-06-27 | — | — | WO | disclosed |
| US-20230183759-A1 | CELLS AND METHODS FOR PRODUCING METHYL KETONES | WISCONSIN ALUMNI RESEARCH FOUNDATION (US) | 2023-06-15 | — | — | US | disclosed |
| CN-115960720-A | Microorganisms and methods for producing fatty alcohols of specific length and related compounds | 基因组股份公司 | 2023-04-14 | — | — | CN | disclosed |
| EP-4153765-A1 | CELLS AND METHODS FOR PRODUCING METHYL KETONES | Wisconsin Alumni Research Foundation (US) | 2023-03-29 | — | — | EP | disclosed |
| CN-104884629-B | Microorganisms and methods for producing fatty alcohols of specific length and related compounds | 基因组股份公司 | 2022-12-20 | — | — | CN | disclosed |
| WO-2010098865-A1 | MAMMALIAN CELL LINE MODELS AND RELATED METHODS | GT LIFE SCIENCES, INC. (US) | 2010-09-02 | — | — | WO | disclosed |
| US-20100143940-A1 | (3R)-HYDROXYACYL-ACP DEHYDRATASE ENZYMES USED IN THE BIOSYNTHESIS OF MYCOLIC ACIDS AND USE OF SAME FOR SCREENING ANTIBIOTICS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2010-06-10 | — | — | US | disclosed |
| EP-2126068-A2 | (3R)-HYDROXYACYL-ACP DEHYDRATASE ENZYMES USED IN THE BIOSYNTHESIS OF MYCOLIC ACIDS AND USE OF SAME FOR SCREENING ANTIBIOTICS | Centre National de la Recherche Scientifique (FR) | 2009-12-02 | — | — | EP | disclosed |
| WO-2009052186-A1 | METABOLOMICS-BASED IDENTIFICATION OF DISEASE-CAUSING AGENTS | GEORGIA TECH RESEARCH CORPORATION (US) | 2009-04-23 | — | — | WO | disclosed |
| WO-2008129146-A2 | (3R)-HYDROXYACYL-ACP DEHYDRATASE ENZYMES INVOLVED IN THE BIOSYNTHESIS OF MYCOLIC ACIDS AND USE OF SAME FOR SCREENING ANTIBIOTICS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2008-10-30 | — | — | WO | disclosed |
| US-20060147899-A1 | Multicellular metabolic models and methods | GENOMATICA, INC. | 2006-07-06 | — | — | US | disclosed |
| EP-1335984-A1 | DETERMINATION OF HYDROPHOBIC COENZYME A ESTERS AND OTHER LIPIDS USING A BIOSENSOR COMPRISING A MODIFIED COENZYME A- AND ACYL-COA BINDING PROTEIN (ACBP) | Biosensor APS (DK) | 2003-08-20 | — | — | EP | disclosed |
| US-20020142347-A1 | Biosensor | BIOSENSOR APS (DK) | 2002-10-03 | — | — | US | disclosed |
| WO-2002061096-A1 | DETERMINATION OF HYDROPHOBIC COENZYME A ESTERS AND OTHER LIPIDS USING A BIOSENS OR COMPRISING A MODIFIED COENZYME A- AND ACYL- BINDING PROTEIN (ACBP) | BIOSENSOR APS (DK) | 2002-08-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100143940-A1 | (3R)-HYDROXYACYL-ACP DEHYDRATASE ENZYMES USED IN THE BIOSYNTHESIS OF MYCOLIC ACIDS AND USE OF SAME FOR SCREENING ANTIBIOTICS | COASY, RIMKLA, HAGH | NAA50 228/4885CHAT 1154/4885EP300 1287/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.